Oruka Therapeutics, Inc. (ORKA)
Across 55 earnings reports since Feb 15, 2005, Oruka Therapeutics, Inc. (ORKA) has a clear post-earnings pattern. It moves ±3.22% on average after reporting and finishes higher 45.5% of the time. Its largest post-earnings gain was +9.23% (May 05, 2006) and its largest decline was -19.4% (Nov 14, 2018). The next earnings report is predicted for 2026-10-16 (estimated).
Earnings reactions
How ORKA moved on each past earnings report.
Earnings Impact
Total Earnings
55
Avg Abs. Movement
±3.22%
Positive %
45.5%
Negative %
54.5%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| Aug 10, 2026 | ☀ PRE | +6.47% | open_in_new |
| Apr 30, 2026 | ☽ POST | -8.58% | open_in_new |
| Sep 05, 2024 | ☽ POST | +2.8% | open_in_new |
| Apr 25, 2024 | ☽ POST | +2.87% | open_in_new |
Earnings Count
55
Total earnings in dataset
Avg Abs. Movement
±3.22%
Avg % price change on earnings
Institutional ownership
Holdings as of Jun 30, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 144 | 20260901 | open_in_new SEC.gov |
| 144 | 20260901 | open_in_new SEC.gov |
| 4 | 20260901 | open_in_new SEC.gov |
| 4 | 20260901 | open_in_new SEC.gov |
| 424B5 | 20260828 | open_in_new SEC.gov |
| EFFECT | 20260827 | open_in_new SEC.gov |
| 3 | 20260825 | open_in_new SEC.gov |
| 4 | 20260825 | open_in_new SEC.gov |
| 8-K | 20260824 | open_in_new SEC.gov |
| S-3 | 20260821 | open_in_new SEC.gov |
Frequently asked about ORKA earnings
When does Oruka Therapeutics, Inc. report earnings next? expand_more
Oruka Therapeutics, Inc. (ORKA)'s next earnings date is estimated for 2026-10-16. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does ORKA stock move after earnings? expand_more
Over 55 reports, ORKA has moved an average of ±3.22% the session after earnings, closing higher 45.5% of the time.
What was ORKA's biggest post-earnings move? expand_more
ORKA's largest post-earnings gain on record was +9.23% on May 05, 2006, and its largest decline was -19.4% on Nov 14, 2018.
Where can I find Oruka Therapeutics, Inc.'s SEC filings? expand_more
All of Oruka Therapeutics, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right